All posts by: Michael Zand

About Michael Zand

Stem cell therapies may soon cure Parkinson’s disease – Gizmodo India

Continue reading

2015-04-08 NEWS

Gizmodo India

Stem cell therapies may soon cure Parkinson’s disease
Gizmodo India
But now Brazilian researchers at D’OR Institute for Research and Education (IDOR) and Federal University of Rio de Janeiro (UFRJ) have taken an important step toward using the implantation of stem cell-generated neurons as a treatment for Parkinson’s …

Continue reading

2015-04-08 NEWS

Proactive Investors Australia

Regeneus hits key stem cell manufacturing milestone
Proactive Investors Australia
Regeneus’ production team leveraged their considerable experience and expertise proven in large-scale stem cell manufacture of CryoShot, the company’s clinical-stage off-the-shelf allogeneic adipose stem cell product for the treatment of canine and
Regeneus completes stem cell manufacture for upcoming trialAustralian Life Scientist

all 2 news articles »

Continue reading

2015-04-08 NEWS

Proactive Investors Australia

Regeneus hits key stem cell manufacturing milestone
Proactive Investors Australia
Regeneus’ production team leveraged their considerable experience and expertise proven in large-scale stem cell manufacture of CryoShot, the company’s clinical-stage off-the-shelf allogeneic adipose stem cell product for the treatment of canine and
Regeneus completes stem cell manufacture for upcoming trialAustralian Life Scientist

all 2 news articles »

Continue reading

2015-04-07 NEWS

Orgenesis to Collaborate With the Global Stem Cell & Regenerative Medicine
CNNMoney
Orgenesis Inc. (OTCQB: ORGS) a cell therapy and regenerative medicine company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-producing cells as a treatment for diabetes, today announced

and more »

Continue reading

2015-04-07 NEWS

Orgenesis to Collaborate With the Global Stem Cell & Regenerative Medicine
CNNMoney
Orgenesis Inc. (OTCQB: ORGS) a cell therapy and regenerative medicine company with a novel therapeutic technology dedicated to converting a patient’s own liver cells into functioning insulin-producing cells as a treatment for diabetes, today announced

and more »